A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Clinical trial NCT04740931 · COMPLETED

Trial details

NCT number: NCT04740931
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Central Retinal Vein Occlusion Hemiretinal Vein Occlusion

Start date: 2021-03-02
Primary completion: 2022-08-09
Enrollment: 729

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.